Apr 21, 2022 / 01:30PM GMT
James Martin - Cocrystal Pharma, Inc. - Co-CEO & CFO
Hello, everyone. I'd like to start by thanking Noble for hosting this conference and for all of you for your interest in Cocrystal Pharma. These are forward-looking statements. I encourage you to read them along with our SEC filings.
So about Cocrystal, we're an antiviral company. We advance high-value antiviral therapeutic drugs. This differentiates us from a vaccine company, and that we do not create vaccines; vaccines are more preventative. We create therapeutics to treat the disease once you have it. This is all driven by our drug discovery platform that was derived from our founders, one of them beyond Nobel Laureate. He took his Nobel experience and put it into a platform to discover drugs.
The investment highlights here at Cocrystal are that we target large global markets where treatment of both acute and pandemic viral diseases. Again, we do have a very strong drug discovery platform that we've developed from our founders and has been used by Merck to develop compounds. We have a number of programs. I think the most
Cocrystal Pharma Inc at Noble Capital Markets Investor Conference (Virtual) Transcript
Mar 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers